Lv32
400 积分 2026-03-27 加入
Risk and Timing of Cardiovascular Disease After Androgen-Deprivation Therapy in Men With Prostate Cancer
6小时前
待确认
An MRI assessment of prostate cancer local recurrence using the PI-RR system: diagnostic accuracy, inter-observer reliability among readers with variable experience, and correlation with PSA values
6小时前
已完结
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)
1天前
已完结
Improved Survival with Enzalutamide in Biochemically Recurrent Prostate Cancer
1天前
已完结
Prognostic Value of PSMA PET–Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer
15天前
已关闭
Prognostic Value of PSMA PET–Derived Tumor Burden Stratification in Metastatic Hormone-Sensitive Prostate Cancer
17天前
已关闭
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
1个月前
已完结
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk and locally advanced prostate cancer: a multicenter, open-label, single-arm, phase II trial
1个月前
已完结
Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (CHART): a randomised, open-label, phase 3 trial
2个月前
已完结
皖公网安备34019202002308
